化合物CCT128930 hydrochloride T6303L
品牌 | 厂商性质 | 产地 | 货期 |
---|---|---|---|
TargetMol | 生产商 | 美国 | 现货 |
性能特点
生化试剂,可用于动物细胞实验
规格 | CAS号 | 价格 | 操作 |
---|---|---|---|
100 mg | 2453324-32-6 | ¥4,650.00 | 询底价 |
10 mg | 2453324-32-6 | ¥1,290.00 | 询底价 |
25 mg | 2453324-32-6 | ¥2,180.00 | 询底价 |
1 mL | 2453324-32-6 | ¥979.00 | 询底价 |
5 mg | 2453324-32-6 | ¥790.00 | 询底价 |
1 mg | 2453324-32-6 | ¥439.00 | 询底价 |
50 mg | 2453324-32-6 | ¥3,250.00 | 询底价 |
2 mg | 2453324-32-6 | ¥579.00 | 询底价 |
Product Introduction
Bioactivity
英文名: CCT128930 hydrochloride
描述: CCT128930 hydrochloride (CCT128930 hydrochloride) 是一种选择性 AKT 抑制剂,具有抗肿瘤活性。它通过靶向 AKT 的 Met282 (PKA-AKT 嵌合体的 Met173),对 PKA 激酶具有 28 倍的选择性,对 p70S6K 具有 20 倍的选择性。
体外活性: In U87MG human glioblastoma cells, CCT128930 hydrochloride(0.1-60 μM; 1 hour) shows an initial induction of AKT phosphorylation at serine 473 up to 20 μM, followed by a decreased in phosphorylation at higher concentrations[1]. CCT128930 (18.9 μM) hydrochloride causes an increase in phosphorylation of pSer473 AKT after 30 minutes, which is sustained for 48 hours. Total AKT protein signal decreases gradually from 8 hours to 48 hours of treatment[1]. The GI50 values of CCT128930 hydrochloride for growth inhibition are 6.3 μM for U87MG human glioblastoma cells, 0.35 μM for LNCaP human prostate cancer cells, and 1.9 μM for PC3 human prostate cancer cells, all of which are PTEN-deficient human tumor cell lines[1]. CCT128930 hydrochloride inhibits direct substrates of AKT (Ser9 GSK3β, pThr246 PRAS40 and pT24 FOXO1/p32 FOXO3a) at ≥5 μM, and the downstream target, pSer235/236 S6RP at ≥10 μM, with generally constant levels of the respective total proteins and GAPDH[1].
体内活性: CCT128930 hydrochloride shows antitumor activities in U87MG and BT474 human breast cancer xenografts[1].
存储条件: Powder: -20°C for 3 years | In solvent: -80°C for 1 year
溶解度: DMSO : 55 mg/mL (145.39 mM)
关键字: CCT128930 hydrochloride | U87MG | cell | phosphorylation | selective | DNA damage | CCT128930 | glioblastoma | Autophagy | arrest | Akt | CCT 128930 Hydrochloride | breast cancer | Inhibitor | BT474 | PTEN | Apoptosis | growth | CCT-128930 Hydrochloride | CCT128930 Hydrochloride | PKB | inhibit | CCT 128930 | CCT-128930 hydrochloride | cycle | CCT-128930 | Protein kinase B
相关产品: Azathioprine | Hexamethonium Bromide | Calcimycin | 9-dihydro-13-acetylbaccatin III | BMS-833923 | GW 441756 | 1-Monopalmitin | Polyinosinic-polycytidylic acid sodium | Aloperine | Gemcitabine elaidate
相关库: Antioxidant Compound Library | PI3K-AKT-mTOR Compound Library | Oxidation-Reduction Compound Library | Anti-Lung Cancer Compound Library | Inhibitor Library | Kinase Inhibitor Library | Tyrosine Kinase Inhibitor Library | Anti-Cancer Active Compound Library | Autophagy Compound Library | Metabolism Compound Library
化合物CCT128930 hydrochloride T6303L信息由TargetMol中国为您提供,如您想了解更多关于化合物CCT128930 hydrochloride T6303L报价、型号、参数等信息,欢迎来电或留言咨询。
注:该产品未在中华人民共和国食品药品监督管理部门申请医疗器械注册和备案,不可用于临床诊断或治疗等相关用途